Compass Therapeutics Statistics

Total Valuation

CMPX has a market cap or net worth of $188.68 million. The enterprise value is $37.95 million.

Market Cap	188.68M
Enterprise Value	37.95M

Important Dates

The next estimated earnings date is Friday, May 10, 2024, before market open.

Earnings Date	May 10, 2024
Ex-Dividend Date	n/a

Share Statistics

CMPX has 127.49 million shares outstanding. The number of shares has increased by 20.76% in one year.

Shares Outstanding	127.49M
Shares Change (YoY)	+20.76%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	13.44%
Owned by Institutions (%)	62.91%
Float	102.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.27
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.73, with a Debt / Equity ratio of 0.01.

Current Ratio	19.73
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -26.10% and return on invested capital (ROIC) is -33.51%.

Return on Equity (ROE)	-26.10%
Return on Assets (ROA)	-24.50%
Return on Capital (ROIC)	-33.51%
Revenue Per Employee	n/a
Profits Per Employee	-$1.33M
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.94% in the last 52 weeks. The beta is 0.60, so CMPX's price volatility has been lower than the market average.

Beta (1Y)	0.60
52-Week Price Change	-43.94%
50-Day Moving Average	1.83
200-Day Moving Average	1.91
Relative Strength Index (RSI)	34.72
Average Volume (30 Days)	376,093

Short Selling Information

The latest short interest is 1.62 million, so 1.27% of the outstanding shares have been sold short.

Short Interest	1.62M
Short Previous Month	1.62M
Short % of Shares Out	1.27%
Short % of Float	1.57%
Short Ratio (days to cover)	3.95

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-50.36M
Pretax Income	-42.49M
Net Income	-42.49M
EBITDA	-40.60M
EBIT	-42.49M
Earnings Per Share (EPS)	-$0.33

Full Income Statement

Balance Sheet

The company has $152.46 million in cash and $1.73 million in debt, giving a net cash position of $150.73 million or $1.18 per share.

Cash & Cash Equivalents	152.46M
Total Debt	1.73M
Net Cash	150.73M
Net Cash Per Share	$1.18
Equity / Book Value	148.54M
Book Value Per Share	1.17
Working Capital	146.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$40.62 million and capital expenditures -$30,000, giving a free cash flow of -$40.65 million.

Operating Cash Flow	-40.62M
Capital Expenditures	-30,000
Free Cash Flow	-40.65M
FCF Per Share	-$0.32

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMPX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.76%
Shareholder Yield	-20.76%
Earnings Yield	-22.52%
FCF Yield	-21.54%

Analyst Forecast

The average price target for CMPX is $9.00, which is 508.11% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	508.11%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3